Sero-prevalence of human parvovirus B19 among patients attending some hospitals in Kano metropolis, Nigeria by Jegede, A et al.
21 
 
ORIGINAL ARTICLE     
AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY.  JANUARY 2014   ISBN 1595-689X VOL15 No.1 
AJCEM/1322       http://www.ajol.info/journals/ajcem 
COPYRIGHT 2014 http://dx.doi.org/10.4314/ajcem.v15i1.4                                                                                                                                                                                                                                                    
AFR. J. CLN. EXPER. MICROBIOL. 15(1): 21-26 
 
SERO-PREVALENCE OF HUMAN PARVOVIRUS B19 AMONG PATIENTS 
ATTENDING SOME HOSPITALS IN KANO METROPOLIS, NIGERIA 
 
Jegede A., Aminu M., Ella EE. 
 
Department of Microbiology, Faculty of Science, Ahmadu Bello University, Zaria-Nigeria 
 
Correspondence: Dr Maryam Aminu, Department of Microbiology, Faculty of Science, Ahmadu Bello University, Zaria- 
Nigeria. Email: maryamaminu@yahoo.com.; 08033287031 
 
ABSRACT 
Background: Human Parvovirus B19 (HPVB19) belongs to the family Parvoviridae, causes Erythema infectiosum, aplastic 
crises in persons with blood disorder and prolonged anaemia in immuno-compromised persons. During pregnancy the 
virus may be transmitted to the foetus which can result in hydrops foetalis, spontaneous abortion or intrauterine foetal 
death. The study determined the sero-prevalence of IgG antibodies to HPVB19 among patients in Kano metropolis in order 
to provide information on their immune status and the possible risk factors for acquiring the virus.  
Method: The study population comprised 460 patients seen at the outpatient department of two hospitals in Kano whose 
mean age was 28.8 (range 0 –70) years. Questionnaire was used to obtain data on socio-demography and risk factors. Blood 
sample was collected from each patient, serum was obtained and analysed for IgG antibodies to HPVB19 by ELISA 
according to manufacturer’s instruction.  
Result/Discussions: Sero-prevalence of 41.5% (191/460) was obtained for HPVB19 and seropositivity increased significantly 
with age with the highest prevalence (51%) recorded among patients ≥51 years old while the lowest prevalence was among 
those < 1 year old (χ2=13.130, df=6, P=0.04). Seropositivity was higher in female (42.6%: 98/230) than male patients (40.4%: 
93/230) (p>0.05). Highest seropositivity was observed among farmers (64.2%:18/28) while the lowest was among retired 
persons (27.2%:3/11). There was significant association between HPVB19 and level of formal education attained (χ2 =10.363, 
df=4, P=0.03) and number of persons living in a house (χ2 =14.30, df=1, P=0.00). There was no association between HPVB19 
and marital status (P=0.3) and type of residence (P=0.5). Blood transfusion (OR=2.0:1; P=0.08) and sickle cell anaemia 
(OR=1.7:1; P=0.08) were important risk factors for HPVB19 transmission in this study. Having blood transfusion showed a 
2.0 fold risk while having sickle cell showed a 1.7 fold risk of acquiring HPVB19 infection. During the study, 48.2% of 
women of child bearing age had antibodies to HPVB19 IgG antibodies leaving about 52% still susceptible to the virus.  
Conclusion:  Seroprevalence to B19 among patients was low leaving a large proportion of the population especially women 
in Kano still susceptible to B19 infection. 
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INTRODUCTION 
Human parvovirus B19 (HPVB19) was accidentally 
discovered during screening of healthy blood 
donors for hepatitis B (1) and has since then been 
recognized as an important human pathogen 
causing significant morbidity and mortality in 
various patient population groups (2). Immature 
cells in the erythroid lineage are principal target for 
human B19 parvovirus. Hence viral replication 
causes cell death, interrupting red cell production 
(3). 
Parvovirus B19 can be found in the blood and 
respiratory secretion of infected patients. The virus 
can be transmitted parentally by blood transfusions, 
infected blood products, packed red cells from 
blood collected during the short viremic phase (4) 
and vertically from mother to foetus (3).  
The virus causes Erythema infectiosum (fifth disease) 
in children and is responsible for various clinical 
manifestations whose characteristics depend on the 
interplay between the viral properties and the 
physiological and immune status of the infected 
individuals (5). Parvovirus B19 virus may cause 
transient anaemia amongst healthy adults, aplastic 
crises in infected persons with an underlying blood 
disorder and prolonged anaemia in immuno-
compromised persons such as AIDS and organ 
transplant patients. In addition, during pregnancy 
the virus may be transmitted to the foetus which 
can result in hydrops foetalis, spontaneous abortion 
or intrauterine foetal death (IUFD), most commonly 
during the second trimester of pregnancy (6). 
However, a persistent infection may be observed in 
immunocompromised patients unable to produce 
neutralizing antibodies and to clear the virus 
leading to chronic B19 carriage with or without 
anaemia (7). Persistence of infection in the bone 
marrow has also been reported in 
immunocompetent individuals with or without 
symptoms (7). 
Though the association between HPVB19 and 
Erythema infectiosum has been established since 
1983, there is dearth of information on the 
prevalence of HPVB19 and associated risk factors in 
Nigeria especially among individuals in Kano state. 
The study therefore aimed at determining the sero-
prevalence of IgG antibodies to Parvovirus B19 
among patients in Kano metropolis in order to 
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provide information on the immune status of the 
general population to the virus and possible risk 
factors for acquiring the virus, with the hope of 
aiding in the control and spread of this virus.  
 
MATERIALS AND METHODS 
The cross sectional study was conducted between 
July and October 2009 in two hospitals in Kano 
state; Hasiya Bayero Paediatric Hospital and Aminu 
Kano Teaching Hospital. The ethical review boards 
in these hospitals approved the study and informed 
consent was obtained from parents/caregivers as 
well as patients before inclusion. The study group 
comprised 460 patients whose mean age was 28.8 
(range 0–70) years. Each enrolled patient had a 
serum specimen tested for the presence of anti-
parvovirus IgG antibodies by enzyme-linked 
immunosorbent assay 
(InstitutViron/serionGMbHWurzbury, Germany). 
Demographic information and data on possible risk 
factors were collected from the patients using 
structured questionnaires prior to sample collection. 
Data obtained from the questionnaires and the 
result from the sample analysis were entered into 
spread sheet and analysed using the SPSS version 
15.0. Prevalence rates of B19 IgG antibodies were 
compared with the parameters by chi-square test. P 
values < 0.05 were considered significance at 95% 
Confidence Interval (CI). 
 
RESULTS 
The sero-prevalence of IgG antibodies to HPVB19 in 
the two hospitals is shown in Table 1. The sero-
prevalence of B19 IgG antibodies increased from 
25.0% (1/4) in children to 51% (24/47) in adults (P = 
0.04). The 460 patients in the study were equally 
distributed between male and female. Though sero-
prevalence was higher in female patients than male 
patients, the difference observed was not statistically 
significant (P=0.3). There was no significance 
difference in the sero-prevalence of the antibodies 
by marital status though prevalence was higher 
among married compared to unmarried patients. 
Level of formal education was significantly 
associated with presence of antibodies to the virus 
with the highest prevalence observed among those 
without formal education (44%: 64/145) while the 
lowest was among those with tertiary education 
(33%:26/78). There was a significant association 
between infection with parvovirus and occupation 
of patients (P=0.02). Farmers had the highest 
prevalence (64%:18/28) of antibodies to Parvovirus 
compared to retirees with the lowest (27.2%: 3/11). 
 
The result was analysed according to type of house 
patients live in and the highest prevalence of 45% 
(90/200) was recorded among patients living in 
family compound house while the lowest (28.5%: 
14/49) was recorded amongst patients who live in 
duplex type of residential houses. The difference 
observed was not statistically significant (P=0.5). 
Further analysis of the results showed that  
parvovirus infection was significantly associated 
with the number of persons living in a house; with 
patients living in houses with more than 5 persons 
having the highest prevalence (51.8%: 99/191) while 
those living in houses with less than 5 persons had 
the least (34.2%: 92/269). 
 
TABLE 1: SERO-PREVALENCE OF HPVB19 IGG ANTIBODIES AMONG PATIENTS 0-70  
YEARS OLD ATTENDING SOME HOSPITALS IN KANO METROPOLIS 
 
Hospital Number Screened Number Positive (%) 95%CI 
AKTH 368 158  (42.9)  37-48 
HBPH 92 33    (35.8)  26-46 
    
Total 460 191  (41.5)  37-46 
χ2 =1.513, df =1, p=0.2 
Key: AKTH = Aminu Kano Teaching Hospital; HBPH =Hasiya Bayero Paediatric Hospital 
 
Some possible risk factors that might be associated 
with transmission of HPVB19 infection among the 
population was analysed (Table 3). The results of 
this study showed that history of transfusion is an 
important factor for acquiring infection with 
HPVB19. There was a 2- fold risk of getting infected 
among those who have had transfusion (95% CI 
=0.8-4.6, OR =2.0) though the difference was not 
statistically significant (χ2=2.917, df=1, P=0.08).  
Others risk factors such as pregnancy, sickle cell 
anaemia and organ transplantation were not 
significantly associated with Parvovirus B19 with 
highest prevalences of  41.5%, 54.5% and 100% and 
lowest prevalences 41.5%,40.9% and 41.4% 
(P=0.9,P=0.2, P=0.2) respectively.  
 
The result was further analysed according to age 
group of the female patients and it was observed 
that women within age group 31-40 years had the 
highest prevalence of HPVB19 IgG (55%: 27/49) and 
the lowest prevalence was recorded among women 
in age group 10-20 years (38%: 13/34) (Table 4). The 
results showed that 170 (73.9%) of the 230 female 
patients studied were of child bearing age and 
HPVB19 IgG antibodies was detected among 48.2% 
(82/170) of these women. Among the women of 
child bearing age, 41/170(24%) were pregnant and 
only 17/41(41.5%) of them had antibodies to 
HPVB19 which leaves about (24/41) 58.5% of those 
pregnant still susceptible to HPVB19 infection.   
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TABLE 2: SOME SOCIO-DEMOGRAPHIC FACTORS ASSOCIATED WITH HPVB19 IGG AMONG PATIENTS IN SELECTED HOSPITALS IN 
KANO METROPOLIS 
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                                        Key: Mean age = 28.8; S.D = 1.6;  Others   = Unskilled labourers, bike riders. 
TABLE 3: SOME POSSIBLE RISK FACTORS ASSOCIATED WITH HPVB19 AMONG PATIENTS ATTENDING SOME SELECTED HOSPITALS 
IN KANO METROPOLIS 
Variable No of patient No.Positive (%) p-value OR 95%CI 
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TABLE 4: DISTRIBUTION OF HUMAN PARVOVIRUS B19 ANTIBODY AMONG WOMEN OF CHILDBEARING AGE ATTENDING SOME 
SELECTED HOSPITALS IN KANO METROPOLIS 
 
Age group (yrs) No. Screened No. Positive       Percentage (%) 95% CI 
 
10-20 34 13                                  38 23-54 
21-30 57 28                                  49 36-61 
31-40 49 27                                  55 41-68 
41-50 30   14                                 46.7 30-63 




The overall prevalence rate of HPVB19 IgG antibody 
determined in this study was 41.5%. This was slightly higher 
than the prevalence of 39.5% reported in Jos (2) and lower 
than the prevalence of 85.4% reported from Zaria (8) other 
studies reported 60-70% from developed countries such as 
England (9) but higher than 16.2% reported in Singapore (10). 
These discrepancies could be due to differences in the 
specificity and sensitivity of the assays used. 
Several studies in different regions of the world have 
identified different socio-demographic variables like age, 
gender, socio-economic status and environmental conditions 
as risk factors for acquisition of parvovirus B19 infection. For 
example, age has been consistently shown to be a major 
predictor of anti-parvovirus B19 IgG seropositivity (11,12,13).  
 
This was also demonstrated in this study where 
seropositivity significantly increased with age; with a 
gradual increase in seropositivity from patients <1 year old 
through ≥ 51years old. The present study, the first in Kano to 
assess HPV B19 IgG sero-prevalence amongst patients, 
shows that by age 20 about 40% of the population have been 
infected by HPV B19. 
 
Parvovirus B19, seropositivity is a synonym of immunity, the 
increase in seroprevalence with age means that, the 
proportion of individuals susceptible to parvovirus B19 
decreases with age (14). This increasing seropositive rate 
with increasing age is consistent with the work of Girei in Jos 
(2) and reports from other countries (11, 5, 15). However, the 
results contrast that of Ujo and colleagues whose study 
reported that seropostivity did not increase with age (8). This 
discrepancy could be due to the fact their study was carried 
out in children with sickle cell disease whereas this study 
was carried out among all kinds of patients in the general 
population aged from 0-70 years.  
 
The prevalence of 51% among age group >51 years found in 
this study is similar to 50% reported in India (15) and slightly 
lower than 55% reported in Malaysia (11) for the same age 
group. This difference could be attributed to dwindling 
immune response in the elderly, as a result of the natural 
decay of antibodies with time, which probably account for 
the lower seropositivity seen in the age group 51 years and 
above (11) as the antibodies could have decreased to a level 
beneath the detection limit of the test used in this study. 
 
This study however has not demonstrated any association 
between gender and seropositivity of parvovirus as the 
difference in the prevalence rates was not significantly 
different between male and female patients. Overall a 
slightly higher seropositivity was observed in female patients 
than in male patients, which is in agreement with the 
findings of Ooi et al in Malaysia (11), Salimi et al in Iran (5) 
and Girei et al in Nigeria (2).  
 
Marital status did not affect the prevalence of the virus in 
this study. No statistically significant difference in the 
positivity was evident among the married patients and the 
unmarried individuals. This was also observed in India 
where the prevalence in married donors was not statistically 
different from the unmarried as transmission of the virus is 
not through sexual route. 
The relationship between socio-economic status and health 
outcome is well known (13). Higher positivity found among 
farmers, bike riders and unskilled labourers could be 
explained by their poor living conditions such as poor 
housing, overcrowding and low educational levels. This 
finding conforms to work of Kishore et al.(15) among blood 
donors in India where high positivity was observed among 
unskilled labourers. Higher prevalence among these 
occupational groups was attributed to outdoor activities 
which could lead to more exposure and thus contact with 
infectious agents (15). High positivity observed in this study 
among full time housewives could also be due to the fact that 
women are always in contact with children both at home and 
outside the home. This finding does not conform to the work 
of Ujo et al. (8) who did not find any association between 
occupation and HPVB19 among parents of children in their 
study. 
 
In this study it was observed that lower educational levels 
and overcrowding predispose to Parvovirus infection. 
Studies have indicated that education, to some extent 
compensates the effects of poverty on health, irrespective of 
the availability of health facilities (15). In this study the 
highest prevalence was observed among those without 
formal education and lowest among the highly educated. 
The finding is consistent with findings of Kishore and 
colleagues on blood donors in India who also reported 
higher prevalence among illiterates, low educated group and 
lowest among the highly educated group (15).  
 
The seroprevalence of parvovirus was significantly higher 
among patients who lived in houses with more than five 
people. This finding is in close agreement with reports of 
Alao and colleagues (13) who reported higher parvovirus 
B19 prevalence rate in Jos among children who lived in 
crowded dwellings which was attributed to overcrowding in 
urban areas. Overcrowding is very common in urban areas 
where most people live in highly compacted areas with little 
or no ventilation. This occurrence is common in a populous 
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country like Nigeria where there is usually an influx of 
people from the rural areas to the urban areas. Overcrowding 
leads to a higher and faster spread of infection through the 
respiratory route (15) and HPVB19 is transmitted primarily 
through respiratory secretions and saliva. Therefore, in 
crowded environments such as daycare centers, 
kindergartens and schools transmission of the virus from 
infected to non-infected individuals is probable (16, 17). 
 
History of transfusion, sickle cell anaemia, being pregnant 
and organ transplant, showed no significant association. 
Higher prevalence observed among the non transfused 
group is in agreement with the work of Ujo and colleagues 
(8) who also found higher prevalence among this group, 
though a 2 fold risk was observed with respect to blood 
transfusion in this study. Although significant association 
was not established, higher prevalence was observed among 
those with sickle cell anaemia disease. Secondary attack rates 
of between 50 to 60% have been reported in families with 
more than one child with sickle cell anaemia when one child 
is acutely infected (13). The prevalence among pregnant and 
those without pregnancy coincides with the overall 
prevalence of 41.5% obtained from the study. Though the 
only organ transplant patient tested positive, number in the 
group was too small to draw any conclusion. There may be 
other factors apart from those studied which contribute to 
transmission of the virus.  
 
In this study, almost half (48.2%) of the women of 
reproductive age defined as women from 10-50 years old (18) 
had IgG antibodies to HPVB19. This finding shows that over 
half (52%) of women within this age group in the study are 
still susceptible to parvovirus B19 infection which poses a 
public health problem. This result is similar to 47% obtained 
in a study in Brazil (19). Parvovirus infection during 
pregnancy can cause severe foetal anaemia as a result of 
foetal erythroid progenitor cell infection with a shortened 
half-life of erythrocytes, causing high output cardiac failure 
and subsequently non-immune hydrops foetalis (16, 17).  
In conclusion, the findings in this study confirmed the 
presence of human parvovirus B19 in Kano state and 
seroprevalence rate comparable with those found in various 
countries in the world. Seroprevalence to HPVB19 among 
patients was low leaving a large proportion of the population 
in Kano still susceptible to HPVB19 infection. 
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